Functional role of miR‑155 in physiological and pathological processes of liver injury (Review)
- Authors:
- Xiao Feng
- Jiaying Bao
- Chunxia Song
- Ling Xie
- Xu Tan
- Jiaqi Li
- Huimin Jia
- Miaomiao Tian
- Jianni Qi
- Chengyong Qin
- Hongjun Bian
-
Affiliations: Department of Gastroenterology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong 250021, P.R. China, Department of Gastroenterology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong 250021, P.R. China, Department of Emergency Medicine, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong 250021, P.R. China, Department of Obstetrics and Gynecology, Jinan Zhangqiu District Maternal and Child Health Hospital, Jinan, Shandong 250200, P.R. China, Department of Gynecology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong 250021, P.R. China, Department of Immunology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong 250021, P.R. China, Department of Central Laboratory, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong 250021, P.R. China - Published online on: August 10, 2021 https://doi.org/10.3892/mmr.2021.12353
- Article Number: 714
This article is mentioned in:
Abstract
|
Losser MR and Payen D: Mechanisms of liver damage. Semin Liver Dis. 16:357–367. 1996. View Article : Google Scholar : PubMed/NCBI | |
|
Asrani SK, Devarbhavi H, Eaton J and Kamath PS: Burden of liver diseases in the world. J Hepatol. 70:151–171. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Plotnikova OM and Skoblov MY: Efficiency of the miRNA-mRNA interaction prediction programs. Mol Biol (Mosk). 52:543–554. 2018.(In Russian). View Article : Google Scholar : PubMed/NCBI | |
|
Lu TX and Rothenberg ME: MicroRNA. J Allergy Clin Immunol. 141:1202–1207. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Zhao Q, Li T, Qi J, Liu J and Qin C: The miR-545/374a cluster encoded in the Ftx lncRNA is overexpressed in HBV-related hepatocellular carcinoma and promotes tumorigenesis and tumor progression. PLoS One. 9:e1097822014. View Article : Google Scholar : PubMed/NCBI | |
|
Qi J, Qiao Y, Wang P, Li S, Zhao W and Gao C: microRNA-210 negatively regulates LPS-induced production of proinflammatory cytokines by targeting NF-κB1 in murine macrophages. FEBS Lett. 586:1201–1207. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Chivukula RR, Shi G, Acharya A, Mills EW, Zeitels LR, Anandam JL, Abdelnaby AA, Balch GC, Mansour JC, Yopp AC, et al: An essential mesenchymal function for miR-143/145 in intestinal epithelial regeneration. Cell. 157:1104–1116. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Bayraktar R and Van Roosbroeck K: miR-155 in cancer drug resistance and as target for miRNA-based therapeutics. Cancer Metastasis Rev. 37:33–44. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang Y, Wei W, Cheng N, Wang K, Li B, Jiang X and Sun S: Hepatitis C virus-induced up-regulation of microRNA-155 promotes hepatocarcinogenesis by activating Wnt signaling. Hepatology. 56:1631–1640. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Shi Y, Li K, Xu K and Liu QH: MiR-155-5p accelerates cerebral ischemia-reperfusion injury via targeting DUSP14 by regulating NF-κB and MAPKs signaling pathways. Eur Rev Med Pharmacol Sci. 24:1408–1419. 2020.PubMed/NCBI | |
|
Zhang Y, Xie Y, Zhang L and Zhao H: MicroRNA-155 participates in smoke-inhalation-induced acute lung injury through inhibition of SOCS-1. Molecules. 25:10222020. View Article : Google Scholar : PubMed/NCBI | |
|
Kandell WM, Donatelli SS, Trinh TL, Calescibetta AR, So T, Tu N, Gilvary DL, Chen X, Cheng P, Adams WA, et al: MicroRNA-155 governs SHIP-1 expression and localization in NK cells and regulates subsequent infiltration into murine AT3 mammary carcinoma. PLoS One. 15:e02258202020. View Article : Google Scholar : PubMed/NCBI | |
|
Quer J, Rodríguez-Frias F, Gregori J, Tabernero D, Soria ME, García-Cehic D, Homs M, Bosch A, Pintó RM, Esteban JI, et al: Deep sequencing in the management of hepatitis virus infections. Virus Res. 239:115–125. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Inoue J, Ninomiya M, Shimosegawa T and McNiven MA: Cellular membrane trafficking machineries used by the hepatitis viruses. Hepatology. 68:751–762. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Appourchaux K, Dokmak S, Resche-Rigon M, Treton X, Lapalus M, Gattolliat CH, Porchet E, Martinot-Peignoux M, Boyer N, Vidaud M, et al: MicroRNA-based diagnostic tools for advanced fibrosis and cirrhosis in patients with chronic hepatitis B and C. Sci Rep. 6:349352016. View Article : Google Scholar : PubMed/NCBI | |
|
Yugo DM, Hauck R, Shivaprasad HL and Meng XJ: Hepatitis virus infections in poultry. Avian Dis. 60:576–588. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Tong S and Revill P: Overview of hepatitis B viral replication and genetic variability. J Hepatol. 64 (Suppl 1):S4–S16. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Sarkar N, Panigrahi R, Pal A, Biswas A, Singh SP, Kar SK, Bandopadhyay M, Das D, Saha D, Kanda T, et al: Expression of microRNA-155 correlates positively with the expression of Toll-like receptor 7 and modulates hepatitis B virus via C/EBP-β in hepatocytes. J Viral Hepat. 22:817–827. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Su C, Hou Z, Zhang C, Tian Z and Zhang J: Ectopic expression of microRNA-155 enhances innate antiviral immunity against HBV infection in human hepatoma cells. Virol J. 8:3542011. View Article : Google Scholar : PubMed/NCBI | |
|
Chen L, Ming X, Li W, Bi M, Yan B, Wang X, Yang P and Yang B: The microRNA-155 mediates hepatitis B virus replication by reinforcing SOCS1 signalling-induced autophagy. Cell Biochem Funct. 38:436–442. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Wang W, Bian H, Li F, Li X, Zhang D, Sun S, Song S, Zhu Q, Ren W, Qin C and Qi J: HBeAg induces the expression of macrophage miR-155 to accelerate liver injury via promoting production of inflammatory cytokines. Cell Mol Life Sci. 75:2627–2641. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Zeisel MB, Felmlee DJ and Baumert TF: Hepatitis C virus entry. Curr Top Microbiol Immunol. 369:87–112. 2013.PubMed/NCBI | |
|
Bala S, Tilahun Y, Taha O, Alao H, Kodys K, Catalano D and Szabo G: Increased microRNA-155 expression in the serum and peripheral monocytes in chronic HCV infection. J Transl Med. 10:1512012. View Article : Google Scholar : PubMed/NCBI | |
|
Kałużna EM: MicroRNA-155 and microRNA-196b: Promising biomarkers in hepatitis C virus infection? Rev Med Virol. 24:169–185. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Grek M, Piekarska A, Bartkowiak J, Fendler W, Kuydowicz J, Wroblewski P, Paradowski M and Sidorkiewicz M: Coordinated increase of miRNA-155 and miRNA-196b expression correlates with the detection of the antigenomic strand of hepatitis C virus in peripheral blood mononuclear cells. Int J Mol Med. 28:875–880. 2011.PubMed/NCBI | |
|
Jiang M, Broering R, Trippler M, Wu J, Zhang E, Zhang X, Gerken G, Lu M and Schlaak JF: MicroRNA-155 controls Toll-like receptor 3- and hepatitis C virus-induced immune responses in the liver. J Viral Hepat. 21:99–110. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Cheng YQ, Ren JP, Zhao J, Wang JM, Zhou Y, Li GY, Moorman JP and Yao ZQ: MicroRNA-155 regulates interferon-g production in natural killer cells via Tim-3 signalling in chronic hepatitis C virus infection. Immunology. 145:485–497. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
McDaniel K, Herrera L, Zhou T, Francis H, Han Y, Levine P, Lin E, Glaser S, Alpini G and Meng F: The functional role of microRNAs in alcoholic liver injury. J Cell Mol Med. 18:197–207. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Park HK, Jo W, Choi HJ, Jang S, Ryu JE, Lee HJ, Lee H, Kim H, Yu ES and Son WC: Time-course changes in the expression levels of miR-122, −155, and −21 as markers of liver cell damage, inflammation, and regeneration in acetaminophen-induced liver injury in rats. J Vet Sci. 17:45–51. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Szabo G and Lippai D: Converging actions of alcohol on liver and brain immune signaling. Int Rev Neurobiol. 118:359–380. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Bala S, Marcos M, Kodys K, Csak T, Catalano D, Mandrekar P and Szabo G: Up-regulation of microRNA-155 in macrophages contributes to increased tumor necrosis factor {alpha} (TNF{alpha}) production via increased mRNA half-life in alcoholic liver disease. J Biol Chem. 286:1436–1444. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Bala S and Szabo G: MicroRNA signature in alcoholic liver disease. Int J Hepatol. 2012:4982322012. View Article : Google Scholar : PubMed/NCBI | |
|
Babuta M, Furi I, Bala S, Bukong TN, Lowe P, Catalano D, Calenda C, Kodys K and Szabo G: Dysregulated autophagy and lysosome function are linked to exosome production by Micro-RNA 155 in alcoholic liver disease. Hepatology. 70:2123–2141. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Katarey D and Verma S: Drug-induced liver injury. Clin Med (Lond). 16 (Suppl 6):S104–S109. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Vinken M, Maes M, Vanhaecke T and Rogiers V: Drug-induced liver injury: Mechanisms, types and biomarkers. Curr Med Chem. 20:3011–3021. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Sutti S and Tacke F: Liver inflammation and regeneration in drug-induced liver injury: Sex matters! Clin Sci (Lond). 132:609–613. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Yuan K, Zhang X, Lv L, Zhang J, Liang W and Wang P: Fine-tuning the expression of microRNA-155 controls acetaminophen-induced liver inflammation. Int Immunopharmacol. 40:339–346. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Glaziou P, Floyd K and Raviglione MC: Global epidemiology of tuberculosis. Semin Respir Crit Care Med. 39:271–285. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Shih TY, Young TH, Lee HS, Hsieh CB and Hu OY: Protective effects of kaempferol on isoniazid- and rifampicin-induced hepatotoxicity. AAPS J. 15:753–762. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Song L, Zhang Z, Zhang J, Zhu X, He L, Shi Z, Gao L and Feng F: Ratio of microRNA-122/155 in isoniazid-induced acute liver injury in mice. Exp Ther Med. 12:889–894. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Tili E, Michaille JJ, Cimino A, Costinean S, Dumitru CD, Adair B, Fabbri M, Alder H, Liu CG, Calin GA and Croce CM: Modulation of miR-155 and miR-125b levels following lipopolysaccharide/TNF-alpha stimulation and their possible roles in regulating the response to endotoxin shock. J Immunol. 179:5082–5089. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Wan C, Han R, Liu L, Zhang F, Li F, Xiang M and Ding W: Role of miR-155 in fluorooctane sulfonate-induced oxidative hepatic damage via the Nrf2-dependent pathway. Toxicol Appl Pharmacol. 295:85–93. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Wang L, Zhang N, Wang Z, Ai DM, Cao ZY and Pan HP: Decreased MiR-155 level in the peripheral blood of non-alcoholic fatty liver disease patients may serve as a biomarker and may influence LXR activity. Cell Physiol Biochem. 39:2239–2248. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Neuschwander-Tetri BA: Non-alcoholic fatty liver disease. BMC Med. 15:452017. View Article : Google Scholar : PubMed/NCBI | |
|
Bala S, Csak T, Saha B, Zatsiorsky J, Kodys K, Catalano D, Satishchandran A and Szabo G: The pro-inflammatory effects of miR-155 promote liver fibrosis and alcohol-induced steatohepatitis. J Hepatol. 64:1378–1387. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Csak T, Bala S, Lippai D, Kodys K, Catalano D, Iracheta-Vellve A and Szabo G: MicroRNA-155 deficiency attenuates liver steatosis and fibrosis without reducing inflammation in a mouse model of steatohepatitis. PLoS One. 10:e01292512015. View Article : Google Scholar : PubMed/NCBI | |
|
Lin X, Jia J, Du T, Li W, Wang X, Wei J, Lin X, Zeng H, Yao L, Chen X, et al: Overexpression of miR-155 in the liver of transgenic mice alters the expression profiling of hepatic genes associated with lipid metabolism. PLoS One. 10:e01184172015. View Article : Google Scholar : PubMed/NCBI | |
|
Tsochatzis EA, Bosch J and Burroughs AK: Liver cirrhosis. Lancet. 383:1749–1761. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Qiang H, Lin Y, Zhang X, Zeng X, Shi J, Chen YX, Yang MF, Han ZG and Xie WF: Differential expression genes analyzed by cDNA array in the regulation of rat hepatic fibrogenesis. Liver Int. 26:1126–1137. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Pinzani M: Epithelial-mesenchymal transition in chronic liver disease: Fibrogenesis or escape from death? J Hepatol. 55:459–465. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Dai W, Zhao J, Tang N, Zeng X, Wu K, Ye C, Shi J, Lu C, Ning B, Zhang J and Lin Y: MicroRNA-155 attenuates activation of hepatic stellate cell by simultaneously preventing EMT process and ERK1 signalling pathway. Liver Int. 35:1234–1243. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Elbekai RH, Korashy HM and El-Kadi AO: The effect of liver cirrhosis on the regulation and expression of drug metabolizing enzymes. Curr Drug Metab. 5:157–167. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Vuppalanchi R, Liang T, Goswami CP, Nalamasu R, Li L, Jones D, Wei R, Liu W, Sarasani V, Janga SC and Chalasani N: Relationship between differential hepatic microRNA expression and decreased hepatic cytochrome P450 3A activity in cirrhosis. PLoS One. 8:e744712013. View Article : Google Scholar : PubMed/NCBI | |
|
Zhai Y, Petrowsky H, Hong JC, Busuttil RW and Kupiec-Weglinski JW: Ischaemia-reperfusion injury in liver transplantation-from bench to bedside. Nat Rev Gastroenterol Hepatol. 10:79–89. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Tang B, Wang Z, Qi G, Yuan S, Yu S, Li B, Wei Y, Huang Q, Zhai R and He S: MicroRNA-155 deficiency attenuates ischemia-reperfusion injury after liver transplantation in mice. Transpl Int. 28:751–760. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Lentsch AB, Kato A, Yoshidome H, McMasters KM and Edwards MJ: Inflammatory mechanisms and therapeutic strategies for warm hepatic ischemia/reperfusion injury. Hepatology. 32:169–173. 2000. View Article : Google Scholar : PubMed/NCBI | |
|
Tan L, Jiang W, Lu A, Cai H and Kong L: miR-155 aggravates liver ischemia/reperfusion injury by suppressing SOCS1 in mice. Transplant Proc. 50:3831–3839. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Li Y, Ma D, Wang Z and Yang J: MicroRNA-155 deficiency in kupffer cells ameliorates liver ischemia-reperfusion injury in mice. Transplantation. 101:1600–1608. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Perry BC, Soltys D, Toledo AH and Toledo-Pereyra LH: Tumor necrosis factor-α in liver ischemia/reperfusion injury. J Invest Surg. 24:178–188. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Xia G, Wu S, Wang X and Fu M: Inhibition of microRNA-155 attenuates concanavalin-A-induced autoimmune hepatitis by regulating Treg/Th17 cell differentiation. Can J Physiol Pharmacol. 96:1293–1300. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Zachou K, Muratori P, Koukoulis GK, Granito A, Gatselis N, Fabbri A, Dalekos GN and Muratori L: Review article: Autoimmune hepatitis-current management and challenges. Aliment Pharmacol Ther. 38:887–913. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Li A, Li J, Bao Y, Yuan D and Huang Z: Xuebijing injection alleviates cytokine-induced inflammatory liver injury in CLP-induced septic rats through induction of suppressor of cytokine signaling 1. Exp Ther Med. 12:1531–1536. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Chen YL, Xu G, Liang X, Wei J, Luo J, Chen GN, Yan XD, Wen XP, Zhong M and Lv X: Inhibition of hepatic cells pyroptosis attenuates CLP-induced acute liver injury. Am J Transl Res. 8:5685–5695. 2016.PubMed/NCBI | |
|
Yang ZB, Chen WW, Chen HP, Cai SX, Lin JD and Qiu LZ: MiR-155 aggravated septic liver injury by oxidative stress-mediated ER stress and mitochondrial dysfunction via targeting Nrf-2. Exp Mol Pathol. 105:387–394. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Lv X, Zhang Y, Cui Y, Ren Y, Li R and Rong Q: Inhibition of microRNA155 relieves sepsisinduced liver injury through inactivating the JAK/STAT pathway. Mol Med Rep. 12:6013–6018. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Li Z, Han S, Jia Y, Yang Y, Han F, Wu G, Li X, Zhang W, Jia W, He X, et al: MCPIP1 regulates RORα expression to protect against liver injury induced by lipopolysaccharide via modulation of miR-155. J Cell Physiol. Feb 27–2019.(Epub ahead of print). doi: 10.1002/jcp.28327. | |
|
Wang X and Ning Q: Immune mediated liver failure. EXCLI J. 13:1131–1144. 2014.PubMed/NCBI | |
|
An F, Gong B, Wang H, Yu D, Zhao G, Lin L, Tang W, Yu H, Bao S and Xie Q: miR-15b and miR-16 regulate TNF mediated hepatocyte apoptosis via BCL2 in acute liver failure. Apoptosis. 17:702–716. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang G, Yan C, Chen D, Wu X, Zhang Y, Zhan Q and An F: Up-regulation of miR-155 contributes to TNF-mediated hepatocyte apoptosis in acute liver failure. Turk J Gastroenterol. 30:475–484. 2019. View Article : Google Scholar : PubMed/NCBI |
